HomeNDC LookupRxCUI directory › RxCUI 318240

Testosterone 75 MG Drug Implant — RxCUI 318240

RxNorm drug concept · Semantic clinical drug
RxCUI 318240 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI318240
Official nameTestosterone 75 MG Drug Implant
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astestosterone 75 MG Implant Pellet; testosterone 75 MG Subcutaneous Pellet Drug Implant
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)496 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Testosterone Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Testosterone gel is a hormone replacement therapy for adult men whose bodies don't produce enough testosterone on their own — a condition called hypogonadism. This can happen becau...
  • What exactly is testosterone gel used for?
  • Yes, location really matters. Testosterone gel 1.62% goes on the shoulders and upper arms only — not the abdomen, chest, genitals, armpits, or knees. Apply it to clean, dry, unbrok...
  • How do I apply it correctly, and does it matter where I put it?
📖 Read our full Testosterone Transdermal Patch guide →

🕸️ Concept Web — How Testosterone 75 MG Drug Implant Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Testosterone 75 MG Drug Implant RxCUI 318240

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Testosterone 10379
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Testopel 353017
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Testosterone Drug Implant 378786
    • Testosterone Drug Implant Product 1164840
    • Testosterone Drug Implant [Testopel] 406252
    • Testopel Drug Implant Product 1182683
    • Drug Implant 657710
    • Drug Implant Product 1151136
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Testosterone 75 MG SCDC · 316777
  • Testosterone Drug Implant SCDF · 378786
  • Testosterone Drug Implant Product SCDG · 1164840

Brand-Name Concepts

  • Testosterone 75 MG Drug Implant [Testopel] SBD · 404405
  • Testosterone 75 MG [Testopel] SBDC · 576368
  • Testosterone Drug Implant [Testopel] SBDF · 406252
  • Testopel Drug Implant Product SBDG · 1182683
  • Testopel BN · 353017

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 318240 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
66887-0004-10 10 AMPULE in 1 BOX (66887-004-10) / 1 PELLET in 1 AMPULE (6... Testopel Endo USA, Inc. 2014-10-31
66887-0004-20 100 AMPULE in 1 BOX (66887-004-20) / 1 PELLET in 1 AMPULE (... Testopel Endo USA, Inc. 2014-10-31
Observed labelers: Endo USA, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.